AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15767639
Drug: Warfarin 1
RxNorm normalized name: warfarin 1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin 1 mg daily
Trial: 9822184
Drug: Esmolol (ultra-short
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (ultra-short acting beta-blocker)
Trial: 6958476
Drug: Corticosteroids and
RxNorm normalized name: Corticosteroids and mydriatics in combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids and beta 2-adrenergic agonist terbutaline (Group 2)
Trial: 6958476
Drug: Beta 2-adrenergic
RxNorm normalized name: 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN
DrugBank: Hydroxypropyl betadex (DB15379)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta 2-adrenergic agonist alone (additional group of 7 patients)
Trial: 20069077
Drug: Clopidogrel 75
RxNorm normalized name: clopidogrel 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 75 mg/day plus aspirin 81 mg/day
Trial: 20069077
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus aspirin 81 mg/day
Trial: 12512888
Drug: Customary oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Customary oral hygiene
Trial: 12512888
Drug: Neglected oral
RxNorm normalized name: Malva neglecta whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neglected oral hygiene
Trial: 27798032
Drug: Fibrinolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolytic therapy
Trial: 24284437
Drug: Isoleucine (5‐216
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoleucine (5‐216 mg · kg(‐1) · d(‐1))
Trial: 24284437
Drug: Leucine (5‐370
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leucine (5‐370 mg · kg(‐1) · d(‐1))
Trial: 24284437
Drug: Valine (5‐236
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valine (5‐236 mg · kg(‐1) · d(‐1))
Trial: 22929451
Drug: 1 drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 drop of cyclopentolate 0.2% and phenylephrine 1% ophthalmic solution
Trial: 22929451
Drug: 3 drops
RxNorm normalized name: UpSpring WellBaby DHA + Vitamin D3 Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 drops of cyclopentolate 0.2% and phenylephrine 1% ophthalmic solution (treatment reference group)
Trial: 22929451
Drug: 0 drops
RxNorm normalized name: MENTHOL 2.7 mg ORAL SUSPENSION/ DROPS [FREEGELLS COUGH DROPS MENTHOL STRAWBERRY 30 DROPS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 drops of cyclopentolate 0.2% and phenylephrine 1% ophthalmic solution (control group)
Trial: 18579668
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate 3000 mg/d
Trial: 18579668
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate 3750 mg/d
Trial: 18579668
Drug: Lanthanum carbonate
RxNorm normalized name: Lanthanum Carbonate
DrugBank: Lanthanum carbonate (DB06792)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanthanum carbonate 4500 mg/d
Trial: 7450412
Drug: Oral 16,16-dimethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 16,16-dimethyl PGE2 at 1 microgram/kg
Trial: 7450412
Drug: Intravenous 16,16-dimethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 16,16-dimethyl PGE2 at 0.1 microgram/kg
Trial: 30907817
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (10,000 IU/day)
Trial: 22866292
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg quick-release lornoxicam (LNX)
Trial: 26043913
Drug: Pelvic floor
RxNorm normalized name: Tenscare Kegel Toner Pelvic Floor Trainer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelvic floor muscle training (PFMT), electrical stimulation (ES), biofeedback plus 1 mg intravaginal estriol (IE)
Trial: 22999793
Drug: Pioglitazone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (30 mg/d)
Trial: 19915017
Drug: Metformin (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (2000 mg/d)
Trial: 3007984
Drug: Neither treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither treatment
Trial: 16625988
Drug: Almotriptan 25
RxNorm normalized name: almotriptan 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 25 mg under fasting condition (reference)
Trial: 16625988
Drug: Almotriptan 25
RxNorm normalized name: almotriptan 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 25 mg under fed condition
Trial: 16625988
Drug: Almotriptan 25
RxNorm normalized name: almotriptan 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 25 mg under fasting and fed conditions
Trial: 1582275
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ODI, HVI, ISI
Trial: 2414580
Drug: Guanfacine 3
RxNorm normalized name: guanfacine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine 3 mg infused over 1 h
Trial: 2414580
Drug: Idazoxan 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idazoxan 0.2 mg/kg i.v. (control)
Trial: 15450785
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/day) for 6 weeks
Trial: 8636370
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human GH administered sc daily at bedtime, target dose of 12 micrograms/kg x day
Trial: 1763227
Drug: CDP-choline 2000
RxNorm normalized name: CDP-choline
DrugBank: Citicoline (DB12153)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP-choline 2000 mg/die e.v. from two weeks before surgery to ten days after surgery, then 1000 mg/die i.m., 15 days per month for 6 months (Group A)
Trial: 1763227
Drug: CDP-choline 100
RxNorm normalized name: CDP-choline
DrugBank: Citicoline (DB12153)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP-choline 100 mg/die from two weeks before surgery to six months after surgery (Group B)
Trial: 6814227
Drug: Propranolol (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (60 to 320 mg/day)
Trial: 6814227
Drug: Verapamil (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (240 to 480 mg/day)
Trial: 3878652
Drug: Isoflurane administered
RxNorm normalized name: Isoflurane
DrugBank: Isoflurane (DB00753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoflurane administered at an inspired concentration of 0.5‐1.5% for 30 minutes after CPB.
Trial: 29091471
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice (BRJ) supplementation (70-ml concentrated, 7.7 mmol)
Trial: 24515273
Drug: AP301 (inhaled,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AP301 (inhaled, single doses up to 120 mg)
Trial: 22563773
Drug: Alfuzosin 10
RxNorm normalized name: Alfuzosin 10mg Oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 10 mg once daily
Trial: 1792912
Drug: Triple intrathecal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple intrathecal injections (TIT)
Trial: 30358831
Drug: DP1-10 cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DP1-10 cocoa extract containing 130 mg (‐)‐epicatechin and 560 mg procyanidins
Trial: 30358831
Drug: DP2-10 cocoa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DP2-10 cocoa extract containing 20 mg (‐)‐epicatechin and 540 mg procyanidins
Trial: 17378788
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia plus intrathecal MgSO(4) (94.5 mg, 6.3%)
Trial: 9505567
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) used off-label in conjunction with antibiotics
Trial: 30790069
Drug: Pegilodecakin monotherapy
RxNorm normalized name: ilodecakin
DrugBank: Ilodecakin (DB06449)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegilodecakin monotherapy
Trial: 25731073
Drug: Educational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Educational intervention (one-page information sheet about hydrocodone-acetaminophen, given and read aloud)
Trial: 23062389
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) nasal aerosol 320 mg/d
Trial: 15110882
Drug: Droperidol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (2.5 mg d.i.v. twice daily for 5 days) combined with granisetron (3 mg d.i.v. on the first day) and dexamethasone (16 mg d.i.v. on the first day, 8 mg d.i.v. on days 2, 3, and 4)
Trial: 15110882
Drug: Placebo combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo combined with granisetron (3 mg d.i.v. on the first day) and dexamethasone (16 mg d.i.v. on the first day, 8 mg d.i.v. on days 2, 3, and 4)
Trial: 15110882
Drug: Droperidol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (2.5 mg d.i.v. twice daily for 5 days)
Trial: 8239224
Drug: Hydroxychloroquine, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine, 400 mg daily
Trial: 15066608
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups combined
Trial: 15613917
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g glucose
Trial: 22363492
Drug: Psilocybin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psilocybin administration
Trial: 15900306
Drug: Statin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin (20 mg lovastatin)
Trial: 363629
Drug: Mazindol (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazindol (two preparations)
Trial: 31255591
Drug: Biannual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biannual mass drug administration (MDA) with praziquantel alone (arm 1)
Trial: 31255591
Drug: Biannual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biannual mass drug administration (MDA) with snail control (arm 2)
Trial: 31255591
Drug: Biannual mass
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biannual mass drug administration (MDA) with behaviour change activities (arm 3)
Trial: 15566075
Drug: Magnetocardiogram (MCG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetocardiogram (MCG)
Trial: 2661768
Drug: Low-dose cyclosporine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cyclosporine plus azathioprine plus prednisolone (group A)
Trial: 21748765
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 400 mg three times a day
Trial: 19916995
Drug: Voriconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voriconazole (400 mg)
Trial: 9314127
Drug: Propranolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.15 mg/kg i.v., n = 60)
Trial: 2425156
Drug: Propranolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.15 mg/kg i.v.)
Trial: 3378554
Drug: Suxamethonium administration
RxNorm normalized name: suxamethonium
DrugBank: Succinylcholine (DB00202)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suxamethonium administration with inhalation induction without pre-treatment
Trial: 29582734
Drug: Norovirus vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norovirus vaccine interest survey
Trial: 20876596
Drug: 0.2 ml
RxNorm normalized name: isopropyl alcohol 0.2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 ml of sucrose 24% given by mouth using a syringe and a soother
Trial: 20876596
Drug: 0.2 ml
RxNorm normalized name: isopropyl alcohol 0.2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 ml of sterile water given by mouth using a syringe and a soother (Control)
Trial: 28657793
Drug: Simvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (80 mg)
Trial: 18376000
Drug: Simvastatin plus
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin plus Ezetimibe (10 mg)
Trial: 11053614
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (2 g daily)
Trial: 24447354
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular heparin 4 kU once a day for 7 days
Trial: 10827333
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral contraceptive (OC)
Trial: 2828818
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg naloxone
Trial: 25203332
Drug: IV ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ketamine 0.5 mg/kg (Group K)
Trial: 25203332
Drug: IV tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV tramadol 0.5 mg/kg (Group T)
Trial: 22753773
Drug: Tocilizumab (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (both doses)
Trial: 16192421
Drug: High-dose hemodialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose hemodialysis
Trial: 12037147
Drug: Low-dose subcutaneous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose subcutaneous ultralente insulin, administered twice daily for a total dose of 0.25 unit per kilogram of body weight per day, plus annual four-day continuous intravenous infusions of insulin.
Trial: 12037147
Drug: Low-dose subcutaneous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose subcutaneous ultralente insulin
Trial: 444954
Drug: Two-drug regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-drug regimen (vinblastine and procarbazine)
Trial: 444954
Drug: Four-drug regimen
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-drug regimen (MVPP)
Trial: 26188373
Drug: PST with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PST with weekly support (n = 106)
Trial: 19154656
Drug: Placebo/Ketamine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo/Ketamine (0.3 mg/kg i.v.)
Trial: 19154656
Drug: Haloperidol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (2 mg)/Ketamine (0.3 mg/kg i.v.)
Trial: 18589555
Drug: Epoetin zeta
RxNorm normalized name: Epoetin zeta
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin zeta (10,000 IU, intravenous bolus injection)
Trial: 18589555
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (10,000 IU, intravenous bolus injection)
Trial: 15760929
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg IM depomedrone
Trial: 26466021
Drug: Drug-coated stent
RxNorm normalized name: castor fiber scent gland secretion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-coated stent (umirolimus-coated)
Trial: 23122684
Drug: CIDR‐4 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIDR‐4 treatment (controlled internal drug release)
Trial: 23122684
Drug: eCG+ECP (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eCG+ECP (200 IU im eCG plus 0.5 mg ECP im)
Trial: 23122684
Drug: ECP (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECP (0.5 mg)
Trial: 16339823
Drug: L-NG-monomethyl-L-arginine (L-NMMA;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NG-monomethyl-L-arginine (L-NMMA; 8 micromol/min)
Trial: 12972844
Drug: Normative Treatment
RxNorm normalized name: K Norm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normative Treatment Planning (NTP) program
Trial: 11069453
Drug: Cryotherapy (liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy (liquid nitrogen spray, two freeze-thaw cycles, each freeze for 5-10 seconds)
Trial: 6360055
Drug: Nifedipine in
RxNorm normalized name: nifedipine Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine in cardioplegic solution
Trial: 18625352
Drug: Protocol A-1
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol A-1 (540 mg I/kg body weight, imaging delay 15s)
Trial: 18625352
Drug: Protocol A-2
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol A-2 (540 mg I/kg body weight, imaging delay 18s)
Trial: 18625352
Drug: Protocol A-3
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol A-3 (540 mg I/kg body weight, imaging delay 21s)
Trial: 7899404
Drug: Captopril (1.5-2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (1.5-2.0 mg/h i.v.)
Trial: 1971504
Drug: Interferon-alpha 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha 4.5 million U/d with zidovudine 200 mg every 4 hours
Trial: 1971504
Drug: Baseline CD4
RxNorm normalized name: CD4 IgG
DrugBank: Recombinant human CD4 immunoglobulin G (DB17812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline CD4 counts below 200 x 10(6) cells/L
Trial: 24618069
Drug: DES ODF
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DES ODF (2.0 mg)
Trial: 22545363
Drug: Hydro alcoholic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydro alcoholic nettle extract (100 mg kg(‐1) for 8 weeks)
Trial: 9797905
Drug: Physiotherapeutic training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapeutic training twice a week for 10 weeks
Trial: 8559437
Drug: Goserelin 3.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.2 mg given as a depot every 28 days for 6 months
Trial: 8559437
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 10 mg from day 16 to day 25 of each month for 6 months
Trial: 2558701
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (100 micrograms - 4000 micrograms)
Trial: 2558701
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (identical dose protocol) in young subjects (24 +/- 3 years)
Trial: 26457099
Drug: Acetate Mafenide
RxNorm normalized name: Mafenide Acetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetate Mafenide ointment (8.5%)
Trial: 16686813
Drug: Shared decision-making
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shared decision-making training for opioid treatment (n=22)
Trial: 11271343
Drug: Steroid withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid withdrawal
Trial: 16157935
Drug: Supportive care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive care alone (no chemotherapy)
Trial: 16157935
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and Supportive care
Trial: 12699097
Drug: Cefoxitin 2
RxNorm normalized name: cefoxitin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin 2 g intravenously (randomised study)
Trial: 2502256
Drug: Oral propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propranolol given in doses that reduced the resting pulse rate by 25%
Trial: 29258111
Drug: Clarithromycin-based triple
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin-based triple therapy (EAC group)
Trial: 25959199
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (RAS inhibitor only)
Trial: 23631971
Drug: Quad-helix/crib treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quad-helix/crib treatment
Trial: 19392993
Drug: Probiotic bacteria
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic bacteria (Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis; Ecologic Panda) administered prenatally to mothers and to their offspring for the first 12 months of life
Trial: 15474245
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg 17beta-estradiol with 10 mg dydrogesterone (HRT)
Trial: 15474245
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg 17beta-estradiol without dydrogesterone (ERT)